NDC 50242-554-01
Ocrevus Zunovo 23000 U/23mL
ocrelizumab and hyaluronidase · INJECTION, SOLUTION
Ocrevus Zunovo is a injection, solution containing ocrelizumab and hyaluronidase at a strength of 23000 U/23mL. Manufactured by Genentech, Inc..
Key Facts
- Brand Name
- Ocrevus Zunovo
- Generic Name
- ocrelizumab and hyaluronidase
- NDC Code (Package)
50242-554-01- NDC Code (Product)
50242-554- Manufacturer
- Genentech, Inc.
- Strength
- 23000 U/23mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761371
- Drug Class
- Endoglycosidase [EPC]; CD20-directed Cytolytic Antibody [EPC]
- Marketing Start
- 09/13/2024
Recall History
No Recall HistoryView Full Drug Page
Ocrevus Zunovo — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.